http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006089443-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_afcfc7af43784847a2171ad49795c3c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_157e952bc396053c77d46c537e8ce4f6
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-30
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30
filingDate 2004-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89a53203db0acbac0819d8c99e801437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_565a7cfe7db51287fce35f33888cba3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b13b98927d74f9c6b1ded25b01e9daa8
publicationDate 2006-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2006089443-A
titleOfInvention Α2 receptor blocker and vasodilator containing indole derivative as active ingredient
abstract PROBLEM TO BE SOLVED: To find a compound having a simpler structure than yohimbine which is a pentacyclic condensed heterocyclic compound and having an action similar to that of yohimbine. SOLUTION: Formula (I): [Chemical 1] (Wherein R 1 represents hydrogen, an alkyl group, an alkenyl group, an alkynyl group, an aromatic group, an aralkyl group, an acyl group, an arylsulfonyl group, an alkylsulfonyl group, or a hydroxyl group; R 2 represents a hydrocarbon group; R 3 , R 4 , R 5 , R 6 and R 7 are the same or different and are hydrogen, halogen, alkyl group or alkoxy group; R 8 is hydrogen or acyl group; n is an integer of 1 to 6; a and b are Same or different 1 or 0) Or a pharmaceutical composition or food composition for blocking α 2 receptor, comprising a compound represented by the formula (1) or a pharmaceutically acceptable salt thereof: [Selection figure] None
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014506230-A
priorityDate 2004-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420489
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8969
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393662
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID798

Total number of triples: 29.